A case of emphysematous pyelonephritis in a patient with rheumatoid arthritis taking corticosteroid and low-dose methotrexate.
Rheumatoid arthritis (RA) is a systemic autoimmune disease that is characterized by chronic synovial inflammation. Patients with RA have increased risk of infection; this is related to RA itself or the adverse effects of medication. In this report, we describe a case of emphysematous pyelonephritis in a patient with RA associated with AA amyloidosis and steroid-induced diabetes mellitus who was taking corticosteroid and low-dose methotrexate.
Watanabe
Hiroshi
H
Department of Gastroenterology and Rheumatology, School of Medicine, Fukushima Medical University, Fukushima, Japan. chiehiro@fmu.ac.jp
Suzuki
Ryoma
R
Asano
Tomoyuki
T
Shio
Kiori
K
Iwadate
Haruyo
H
Kobayashi
Hiroko
H
Matsuoka
Toshimitsu
T
Aikawa
Ken
K
Ohira
Hiromasa
H
D000368:Aged; D000686:Amyloidosis / Q000150:complications / Q000276:immunology / Q000473:pathology; D001172:Arthritis, Rheumatoid / Q000150:complications* / Q000188:drug therapy / Q000276:immunology; D003920:Diabetes Mellitus / Q000139:chemically induced; D004305:Dose-Response Relationship, Drug; D004646:Emphysema / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D005260:Female; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D008727:Methotrexate / Q000009:adverse effects*; D011704:Pyelonephritis / Q000209:etiology* / Q000473:pathology; D000685:Serum Amyloid A Protein / Q000032:analysis
D005938:Glucocorticoids; D007166:Immunosuppressive Agents; D000685:Serum Amyloid A Protein; D008727:Methotrexate